{"disease":{"id":"respiratory-system-diseases","name":"respiratory system diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07196917","title":"Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05013944","title":"AnovaOS Network Powered Patient Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Anova Enterprises, Inc","has_results":false},{"nct_id":"NCT04977739","title":"Research on the Application and Mechanism of New Biological Probes in Biomedicine","phase":"","overall_status":"COMPLETED","enrollment_count":737,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03037385","title":"Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":590,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT07400133","title":"Assessing Feasibility of a Digital Health Intervention for Multiple Long-Term Condition Care in Primary Health Settings in India and Nepal","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Centre for Chronic Disease Control, India","has_results":false},{"nct_id":"NCT03688074","title":"Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT06272370","title":"Individualizing Treatment for Asthma in Primary Care","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"DARTNet Institute","has_results":true},{"nct_id":"NCT05299385","title":"The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Lifesemantics Corp.","has_results":false},{"nct_id":"NCT05328492","title":"Volume Mode Non-invasive Ventilation in Amyotrophic Lateral Sclerosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University Hospitals Coventry and Warwickshire NHS Trust","has_results":false},{"nct_id":"NCT04729478","title":"Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy in Patients With Obstructive Sleep Apnea","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"ethisch.comite@uza.be","has_results":false},{"nct_id":"NCT02897778","title":"Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Syndax Pharmaceuticals","has_results":false},{"nct_id":"NCT02909452","title":"Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Syndax Pharmaceuticals","has_results":false},{"nct_id":"NCT02130882","title":"Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04644315","title":"A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}